Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Zhejiang Univ Sci B ; 17(6): 425-36, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27256676

RESUMEN

Blueberries are a rich source of anthocyanins, which are associated with health benefits contributing to a reduced risk for many diseases. The present study identified the functional Gardenblue blueberry (Vaccinium ashei Reade) anthocyanin extracts (GBBAEs) and evaluated their capacity and underlying mechanisms in protecting murine RAW 264.7 cells from lipopolysaccharide (LPS)-stimulated inflammation in vitro. Enzyme-linked immunosorbent assay (ELISA) kit results showed that GBBAEs significantly inhibited the production of nitric oxide (NO), prostaglandin E2 (PGE2), interleukin-6 (IL-6), IL-1ß, and interferon-γ (INF-γ). Real-time polymerase chain reaction (PCR) analysis indicated that the mRNA expression levels of IL-6, IL-1ß, tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1), and cyclooxygenase 2 (COX-2) were suppressed in LPS-stimulated RAW 264.7 cells. Additionally, Western blot analysis was used to evaluate the relative protein expression levels of COX-2 and nuclear factor-κB p65 (NF-κBp65). All these results suggested the potential use of GBBAEs as a functional food for the treatment of inflammatory diseases.


Asunto(s)
Antocianinas/farmacología , Antiinflamatorios/farmacología , Arándanos Azules (Planta) , Extractos Vegetales/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ciclooxigenasa 2/genética , Citocinas/genética , Lipopolisacáridos/farmacología , Ratones , Óxido Nítrico/biosíntesis , Factor de Transcripción ReIA/genética
2.
Food Funct ; 6(9): 3045-55, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26201407

RESUMEN

This study was aimed at evaluating the hypouricemic effect of the anthocyanin-rich purple sweet potato extract (APSPE). In vitro, APSPE has been proved to significantly inhibit XO activity in a dose-dependent manner. In vivo, APSPE could not only inhibit the XO activity in mouse liver, but also reduce the serum uric acid level in hyperuricemic mice and affect the expression of mRNA levels of related renal transporters, such as mURAT1, mGLUT9, mOAT1 and mOCTN2. Moreover, APSPE could effectively regulate BUN and Cr levels to normal and decrease the inflammatory cellular influx in the tubule of the hyperuricemic mice. This study indicates the potential clinical utility of APSPE as a safe and effective anti-hyperuricemia bioactive agent or functional food.


Asunto(s)
Antocianinas/administración & dosificación , Hiperuricemia/tratamiento farmacológico , Ipomoea batatas/química , Extractos Vegetales/administración & dosificación , Ácido Úrico/sangre , Xantina Oxidasa/sangre , Animales , Antocianinas/química , Proteínas Facilitadoras del Transporte de la Glucosa/genética , Proteínas Facilitadoras del Transporte de la Glucosa/metabolismo , Humanos , Hiperuricemia/sangre , Riñón/efectos de los fármacos , Riñón/metabolismo , Masculino , Ratones , Proteína 1 de Transporte de Anión Orgánico/genética , Proteína 1 de Transporte de Anión Orgánico/metabolismo , Transportadores de Anión Orgánico/genética , Transportadores de Anión Orgánico/metabolismo , Extractos Vegetales/química , Xantina Oxidasa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA